Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Viral Acute Respiratory Illnesses in Young Infants Increase the Risk of Respiratory Readmission

Toizumi, Michiko, MD, PhD*; Suzuki, Motoi, MD, PhD; Nguyen, Hien Anh Thi, MSc; Le, Minh Nhat, PhD*; Ariyoshi, Koya, MD, PhD†,§; Moriuchi, Hiroyuki, MD, PhD§,¶; Hashizume, Masahiro, MD, PhD*,§; Dang, Duc Anh, PhD; Yoshida, Lay-Myint, MD, PhD*,§

The Pediatric Infectious Disease Journal: December 2018 - Volume 37 - Issue 12 - p 1217–1222
doi: 10.1097/INF.0000000000001998
Original Studies
Buy
SDC

Background: Respiratory viruses cause acute respiratory illness (ARI) in early childhood, but their effect on subsequent ARI admissions is not fully understood. This study aimed to determine the association between initial ARI admission because of viruses including human rhinovirus (HRV), respiratory syncytial virus (RSV), human adenovirus (HAdV) and human metapneumovirus (hMPV) and the risk of ARI readmission in children.

Methods: Clinical information and nasopharyngeal swab samples were collected from children <2 years old at their initial ARI admission in Nha Trang, Vietnam, from January 2007 to April 2012. The incidence of ARI readmission during the follow-up period (initial admission to 5 years of age) was compared between children with and without 1 of 13 respiratory viruses (influenza virus A, influenza virus B, RSV, hMPV, parainfluenza virus-1, parainfluenza virus-2, parainfluenza virus-3 and parainfluenza virus-4, HRV, human coronavirus-229E, human coronavirus-OC43, HAdV and human bocavirus) at initial admission.

Results: A total of 1941 children were enrolled in the study. Viruses were detected in 1254 (64.6%) children at enrollment; HRV, RSV, HAdV and hMPV were detected in 499 (25.7%), 439 (22.6%), 156 (8.0%) and 47 (2.4%) children, respectively. During the follow-up period (4572.7 person-years), 277 children were readmitted with ARI. Virus-related ARI initial admission was associated with an increased risk of ARI readmission for children who were initially admitted before 6 months of age (adjusted rate ratio, 1.6; 95% confidence interval: 1.1–2.5). HAdV (4.6; 1.8–11.9), hMPV (20.4; 6.2–66.9) and HRV (1.6; 1.0–2.4) were independently associated with the outcome. These associations were not observed for children whose initial admission occurred after 6 months of age.

Conclusions: HAdV-, hMPV- and HRV-related initial ARI admissions, when occurring during early infancy, increased the risk of subsequent ARI-related readmission.

From the *Department of Pediatric Infectious Diseases

Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan

Department of Bacteriology, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam

§Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan

Department of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan.

Accepted for publication March 12, 2018.

This was a collaborative research effort between Nagasaki University (Japan), NIHE (Vietnam), Khanh Hoa Provincial Public Health Service (Vietnam) and Khanh Hoa General Hospital (Vietnam).

The study was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID; grant number 10008012) from Ministry of Education, Culture, Sport, Science & Technology in Japan; Japan Agency for Medical Research and Development (AMED; grant number 21406028); Grants-in-Aid for Scientific Research (Japan Society for the Promotion of Science; grant number 15K09571 and Morinaga Hoshikai.

The authors have no conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).

Address for correspondence: Lay-Myint Yoshida, MD, PhD, Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852–8523, Japan. E-mail: lmyoshi@nagasaki-u.ac.jp.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.